Healthcare provider profile · identity verified

Mason Michael Sopchak, DO

Family Practice · DRYDEN, NY · NPI 1679808885

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	293	79
Amlodipine Besylate	Amlodipine Besylate	200	59
Levothyroxine Sodium	Levothyroxine Sodium	190	53
Famotidine	Famotidine	115	37
Lisinopril	Lisinopril	111	32
Omeprazole	Omeprazole	107	33
Allopurinol	Allopurinol	106	27
Losartan Potassium	Losartan Potassium	97	33
Albuterol Sulfate Hfa	Albuterol Sulfate	90	31
Rosuvastatin Calcium	Rosuvastatin Calcium	87	28
Fluticasone Propionate	Fluticasone Propionate	86	32
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	84	14
Metformin Hcl	Metformin Hcl	83	24
Pantoprazole Sodium	Pantoprazole Sodium	76	23
Alprazolam	Alprazolam	75	18
Candesartan Cilexetil	Candesartan Cilexetil	71	20
Metoprolol Succinate	Metoprolol Succinate	67	19
Gabapentin	Gabapentin	65	24
Pravastatin Sodium	Pravastatin Sodium	63	19
Simvastatin	Simvastatin	59	17
Hydrochlorothiazide	Hydrochlorothiazide	56	16
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	56	12
Furosemide	Furosemide	54	20
Potassium Chloride	Potassium Chloride	54	19
Escitalopram Oxalate	Escitalopram Oxalate	53	13
Tamsulosin Hcl	Tamsulosin Hcl	53	18
Irbesartan	Irbesartan	52	16
Metoprolol Tartrate	Metoprolol Tartrate	50	15
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	49	11
Ozempic	Semaglutide	49	suppressed
Alendronate Sodium	Alendronate Sodium	48	14
Oxycodone Hcl	Oxycodone Hcl	48	11
Jardiance	Empagliflozin	45	suppressed
Sertraline Hcl	Sertraline Hcl	45	15
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	44	13
Clopidogrel	Clopidogrel Bisulfate	37	suppressed
Bupropion Xl	Bupropion Hcl	36	11
Entresto	Sacubitril/Valsartan	36	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	34	24
Montelukast Sodium	Montelukast Sodium	34	suppressed
Nystatin	Nystatin	34	12
Fluoxetine Hcl	Fluoxetine Hcl	33	suppressed
Hydrocortisone	Hydrocortisone	32	suppressed
Mirtazapine	Mirtazapine	32	suppressed
Clonazepam	Clonazepam	31	suppressed
Paroxetine Hcl	Paroxetine Hcl	31	suppressed
Chlorthalidone	Chlorthalidone	30	12
Duloxetine Hcl	Duloxetine Hcl	30	suppressed
Methadone Hcl	Methadone Hcl	30	suppressed
Warfarin Sodium	Warfarin Sodium	30	suppressed
Trazodone Hcl	Trazodone Hcl	29	suppressed
Baclofen	Baclofen	28	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	28	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	28	11
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	27	21
Fluconazole	Fluconazole	27	11
Zolpidem Tartrate	Zolpidem Tartrate	27	suppressed
Atenolol	Atenolol	26	suppressed
Pregabalin	Pregabalin	24	suppressed
Tizanidine Hcl	Tizanidine Hcl	24	suppressed
Januvia	Sitagliptin Phosphate	23	suppressed
Tramadol Hcl	Tramadol Hcl	23	suppressed
Ketoconazole	Ketoconazole	22	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	21	suppressed
Diazepam	Diazepam	21	suppressed
Azithromycin	Azithromycin	20	19
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	20	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	20	14
Ibuprofen	Ibuprofen	19	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	19	suppressed
Breo Ellipta	Fluticasone/Vilanterol	18	suppressed
Bupropion Hcl Sr	Bupropion Hcl	18	suppressed
Finasteride	Finasteride	18	suppressed
Prednisone	Prednisone	18	15
Propranolol Hcl	Propranolol Hcl	18	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	17	suppressed
Buprenorphine-Naloxone	Buprenorphine Hcl/Naloxone Hcl	17	suppressed
Dutasteride	Dutasteride	17	suppressed
Eliquis	Apixaban	17	suppressed
Incruse Ellipta	Umeclidinium Bromide	17	suppressed
Janumet Xr	Sitagliptin Phos/Metformin Hcl	17	suppressed
Meloxicam	Meloxicam	17	suppressed
Memantine Hcl Er	Memantine Hcl	17	suppressed
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	17	suppressed
Carisoprodol	Carisoprodol	16	suppressed
Enalapril Maleate	Enalapril Maleate	16	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	16	suppressed
Prazosin Hcl	Prazosin Hcl	16	suppressed
Valacyclovir	Valacyclovir Hcl	16	suppressed
Verapamil Sr	Verapamil Hcl	16	suppressed
Glipizide Er	Glipizide	15	suppressed
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	15	suppressed
Rybelsus	Semaglutide	15	suppressed
Ventolin Hfa	Albuterol Sulfate	15	suppressed
Xarelto	Rivaroxaban	15	suppressed
Bisoprolol Fumarate	Bisoprolol Fumarate	14	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	14	suppressed
Meclizine Hcl	Meclizine Hcl	14	suppressed
Naltrexone Hcl	Naltrexone Hcl	14	suppressed
Fentanyl	Fentanyl	13	suppressed
Nortriptyline Hcl	Nortriptyline Hcl	13	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	13	13
Ramipril	Ramipril	13	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	13	suppressed
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	13	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	12	suppressed
Carvedilol	Carvedilol	12	suppressed
Colestipol Hcl	Colestipol Hcl	12	suppressed
Doxycycline Monohydrate	Doxycycline Monohydrate	12	suppressed
Midodrine Hcl	Midodrine Hcl	12	suppressed
Ondansetron Hcl	Ondansetron Hcl	12	suppressed
Rexulti	Brexpiprazole	12	suppressed
Ropinirole Hcl	Ropinirole Hcl	12	suppressed
Sucralfate	Sucralfate	12	suppressed
Terbinafine Hcl	Terbinafine Hcl	12	suppressed
Acarbose	Acarbose	11	suppressed
Amoxicillin	Amoxicillin	11	suppressed
Buprenorphine	Buprenorphine	11	suppressed
Buspirone Hcl	Buspirone Hcl	11	suppressed
Celecoxib	Celecoxib	11	suppressed
Citalopram Hbr	Citalopram Hydrobromide	11	suppressed
Diphenoxylate-Atropine	Diphenoxylate Hcl/Atropine	11	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	11	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	11	suppressed
Telmisartan	Telmisartan	11	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error